{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:47:31Z","timestamp":1758980851938},"reference-count":2,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:p>This reply to the letter by Hubiche et al. further discusses the hypothesis that geographic tongue is a novel entity related to bevacizumab therapy.<\/jats:p>","DOI":"10.1634\/theoncologist.2012-0421","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T04:15:13Z","timestamp":1365653713000},"page":"e18-e18","source":"Crossref","is-referenced-by-count":3,"title":["In Reply"],"prefix":"10.1093","volume":"18","author":[{"given":"Alyx C.","family":"Rosen","sequence":"first","affiliation":[{"name":"a Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor T.","family":"Gavrilovic","sequence":"additional","affiliation":[{"name":"b Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeniy","family":"Balagula","sequence":"additional","affiliation":[{"name":"a Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Ramaswamy","sequence":"additional","affiliation":[{"name":"c Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura N.","family":"Dickler","sequence":"additional","affiliation":[{"name":"d Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira J.","family":"Dunkel","sequence":"additional","affiliation":[{"name":"c Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[{"name":"a Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"2021122308261299900_B1","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1634\/theoncologist.2012-0320","article-title":"Geographic tongue induced by angiogenesis inhibitors","volume":"18","author":"Hubiche","year":"2013","journal-title":"The Oncologist"},{"key":"2021122308261299900_B2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.oraloncology.2011.03.028","article-title":"Oral complications of targeted cancer therapies: A narrative literature review","volume":"47","author":"Watters","year":"2011","journal-title":"Oral Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2012-0421","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0421","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/4\/e18\/41856048\/oncolo_18_4_e18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/4\/e18\/41856048\/oncolo_18_4_e18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T08:28:41Z","timestamp":1640248121000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/18\/4\/e18\/6398717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":2,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,10]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0421","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4,1]]},"published":{"date-parts":[[2013,4,1]]}}}